Identification and predictive machine learning model construction of gut microbiota associated with carcinoembryonic antigens in colorectal cancer.

[UNLABELLED] Carcinoembryonic antigen (CEA) is a critical colorectal cancer (CRC) biomarker, but its mechanistic link to gut microbiota remains unclear. This study characterized gut microbiota differences between high-CEA (H-CEA) and low-CEA (L-CEA) CRC patients and explored their associations with host immunity and tumor progression mechanisms. Stool samples from 187 CRC patients were subjected to 16S rRNA sequencing, identifying 30 differentially abundant bacteria using LEfSe analysis. was significantly enriched in H-CEA patients. Transcriptome sequencing of tumor tissues from 25 patients revealed distinct immune micro-environments: H-CEA patients showed elevated resting memory CD4 T cells, while L-CEA patients showed increased T follicular helper cells. Functional enrichment analysis identified differential GO terms (26 in L-CEA; 31 in H-CEA) and KEGG pathways (three in H-CEA). correlated positively with mast cell infiltration, CXCL1 chemokine, and long-chain fatty acid upregulation. The area under the curve (AUC) values of the subjects in the training set for the RF and XGBoost models constructed based on differential gut microbiota for predicting high and low CEA levels were 0.969 and 0.815, respectively, and the AUC for the test set were 0.715 and 0.639. These findings demonstrate that CEA-level-specific gut microbiota dysbiosis modulates CRC progression through immune micro-environment alterations and related biological pathway regulation. Gut microbiota, as a noninvasive biomarker, can be used to construct an effective machine learning (ML) model for predicting blood CEA levels.

[IMPORTANCE] This study reveals as a key gut microbiota species enriched in CRC patients with high CEA levels, demonstrating its novel pro-tumor associations through positive correlations with mast cell infiltration and CXCL1 chemokine and upregulation of long-chain fatty acid metabolism. Concurrently, we identify distinct immune micro-environments: elevated resting memory CD4+ T cells in high-CEA patients versus increased T follicular helper cells in low-CEA cohorts. Critically, by leveraging 30 differential microbial features, we develop ML models for noninvasive prediction of CEA levels. These findings establish gut microbiota as both a mechanistic mediator of CEA-driven CRC progression and a foundation for microbiome-based diagnostic tools.